Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Lower doses of topotecan are safe for eyes, but higher doses may harm the retina.

Rat hair follicle stem cells have functional oxytocin receptors, useful for studying neuropsychiatric disorders.

Promising cancer treatments were found, but the manufacturer closed.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

High wool density in Rex rabbits is linked to specific gene activity affecting hair follicle development.

Testosterone reduces knee flexibility by affecting relaxin receptors.

Enzyme purified and characterized for minoxidil sulphation in rat liver.

Rash from EGFRI treatment can indicate both side effects and treatment effectiveness.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

MXD@CP could be a promising new topical treatment for hair loss.

TRPS1 is crucial for bone, kidney, and hair follicle development.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

ISX9 helps regrow hair by activating a specific cell signaling pathway.

Controlling transposable elements is crucial for successful tissue regeneration.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

17β-estradiol can reduce inflammation in the skin.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Isoxazole 9 (ISX9) may help regrow hair by activating certain cell signals.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.